Next Century Growth Investors LLC Acquires New Stake in CeriBell (NASDAQ:CBLL)

Next Century Growth Investors LLC purchased a new position in shares of CeriBell (NASDAQ:CBLL - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 204,760 shares of the company's stock, valued at approximately $5,299,000. Next Century Growth Investors LLC owned about 0.57% of CeriBell as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Legal & General Group Plc bought a new position in CeriBell during the 4th quarter worth approximately $32,000. PNC Financial Services Group Inc. bought a new position in CeriBell during the fourth quarter worth $47,000. Corebridge Financial Inc. acquired a new position in CeriBell in the fourth quarter worth $158,000. Wells Fargo & Company MN bought a new stake in CeriBell during the fourth quarter valued at $167,000. Finally, Invesco Ltd. acquired a new stake in shares of CeriBell during the fourth quarter worth $252,000.

Wall Street Analyst Weigh In

CBLL has been the subject of a number of recent research reports. Canaccord Genuity Group reaffirmed a "buy" rating and set a $33.00 price objective on shares of CeriBell in a research report on Wednesday, February 26th. LADENBURG THALM/SH SH started coverage on CeriBell in a report on Friday, April 4th. They set a "buy" rating and a $32.00 target price for the company. Seven analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $32.50.

Remove Ads

CeriBell Trading Down 2.1 %

NASDAQ CBLL traded down $0.31 on Tuesday, hitting $14.57. The stock had a trading volume of 250,201 shares, compared to its average volume of 265,985. The firm's 50-day simple moving average is $20.72. CeriBell has a one year low of $10.01 and a one year high of $32.75.

CeriBell (NASDAQ:CBLL - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.32) by ($0.08). The company had revenue of $18.53 million during the quarter, compared to analyst estimates of $17.55 million. As a group, equities research analysts expect that CeriBell will post -2.46 earnings per share for the current fiscal year.

About CeriBell

We are a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. We have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting.